Ongoing clonal evolution in chronic myelomonocytic leukemia on hypomethylating agents: a computational perspective.

导出 OA

翻译打印收藏纠错

第一作者： Hein,Than

第一单位： Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.;Department of Hematology, Singapore General Hospital, Singapore, Singapore.

作者： Hein,Than ^[1] ; Yi,Qiao ^[2] ; Xiaomeng,Huang ^[2] ; Dongqing,Yan ^[3] ; Jamshid S,Khorashad ^[4] ; Anthony D,Pomicter ^[3] ; Tibor J,Kovacsovics ^[5] ; Gabor T,Marth ^[2] ; Thomas,O'Hare ^[6] ; Michael W,Deininger ^[7]

作者单位： Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.;Department of Hematology, Singapore General Hospital, Singapore, Singapore. ^[1] Eccles Institute of Human Genetics, The University of Utah, Salt Lake City, UT, USA. ^[2] Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA. ^[3] Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.;Centre for Hematology, Department of Medicine, Imperial College, London, UK. ^[4] Centre for Hematology, Department of Medicine, Imperial College, London, UK. ^[5] Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.;Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, UT, USA. ^[6] Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA. michael.deininger@hci.utah.edu.;Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, UT, USA. michael.deininger@hci.utah.edu. ^[7]